肝动脉化疗栓塞治疗难治性肝癌的若干问题

肝动脉化疗栓塞(transcatheter hepatic artery chemoembolization,TACE)已成为非手术治疗肝癌的首选方法。但是,遇到有些情况,TACE仍然比较难治。难治性肝癌应该包括：肿块较大；病灶较多；肝功能较差；伴有门静脉癌栓；伴有门脉高压、脾功能亢进；或伴有肝动脉-门静脉分流、肝动脉-肝静脉分流；或伴有糖尿病、高血压、冠心病等情况。这些情况都必须慎重处理,采取相应措施,才能延长患者生命。

Several problems involving interventional treatment through transcatheter hepatic artery chemoembolization for refractory hepatic carcinoma

Transcatheter hepatic artery chemoembolization(TACE)has become the primary non-surgery treatment for hepatic carcinoma.Nevertheless,some patients with refractory hepatic carcinoma,such as large tumor mass,multiple tumors,poor hepatic function,presence of portal carcinoma emboli,associated with portal hypertension and hypersplenism and still more with hepatic arteriovenous shunt,DM,HBP,CHD and so on,are hardly to be treated by TACE,and thus more cautious measures should be taken to prolong the patients survival,otherwise inadequate measures may accelerate the mortality.